Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability
Authors
Keywords
-
Journal
DRUG DELIVERY
Volume 23, Issue 9, Pages 3712-3723
Publisher
Informa UK Limited
Online
2016-09-30
DOI
10.1080/10717544.2016.1223225
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Formulation and development of ophthalmicin situgel for the treatment ocular inflammation and infection using application of quality by design concept
- (2016) Nirav Patel et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Nanoemulsion: for improved oral delivery of repaglinide
- (2015) Juber Akhtar et al. DRUG DELIVERY
- Design and evaluation of oral nanoemulsion drug delivery system of mebudipine
- (2015) Samira Khani et al. DRUG DELIVERY
- Bleomycin A6-loaded anionic liposomes within situgel as a new antitumoral drug delivery system
- (2014) Weiming Ding et al. DRUG DELIVERY
- A Validated Specific Stability-Indicating RP-HPLC Assay Method for the Determination of Loteprednol Etabonate in Eye Drops
- (2014) Yong K. Han et al. JOURNAL OF CHROMATOGRAPHIC SCIENCE
- Formulation of nanoemulsion: a comparison between phase inversion composition method and high-pressure homogenization method
- (2013) Sabna Kotta et al. DRUG DELIVERY
- Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: Design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits
- (2013) Saadia Ahmed Tayel et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery
- (2013) Philippe Daull et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Design and development of a novel pH triggered nanoemulsifiedin-situophthalmic gel of fluconazole:Ex-vivotranscorneal permeation, corneal toxicity and irritation testing
- (2012) Mukesh K. Pathak et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Applications of NMR in the characterization of pharmaceutical microemulsions
- (2012) Rania M. Hathout et al. JOURNAL OF CONTROLLED RELEASE
- Moxifloxacin-gelrite In Situ ophthalmic gelling system against photodynamic therapy for treatment of bacterial corneal inflammation
- (2011) Hanan M. El-Laithy et al. ARCHIVES OF PHARMACAL RESEARCH
- Design and development of nanoemulsion drug delivery system of amlodipine besilate for improvement of oral bioavailability
- (2011) Gulshan Chhabra et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery
- (2010) H.O. Ammar et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Nanoemulsion as a Potential Ophthalmic Delivery System for Dorzolamide Hydrochloride
- (2009) Hussein O. Ammar et al. AAPS PHARMSCITECH
- Nanoemulsion Components Screening and Selection: a Technical Note
- (2009) Adnan Azeem et al. AAPS PHARMSCITECH
- In situ gels of Metoclopramide Hydrochloride for intranasal delivery: In vitro evaluation and in vivo pharmacokinetic study in rabbits
- (2009) Hitendra S. Mahajan et al. DRUG DELIVERY
- Formulation and Characterization of Nanoemulsion-Based Drug Delivery System of Risperidone
- (2008) Mukesh Kumar et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- In vitro and in vivo characteristics of a thermogelling and bioadhesive delivery system intended for rectal administration of quinine in children
- (2007) A.A. Koffi et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More